In a blog post, the tech giant said that it is now bringing the Veo 3 series models out of preview. The company first added the video generation models to the platform in June, and claims that so far, ...

Wall Street analysts forecast that Vertex Pharmaceuticals (VRTX) will report quarterly earnings of $4.24 per share in its upcoming release, pointing to a year-over-year increase of 133.1%. It is ...

Vertex Pharmaceuticals is making waves, popping up as one of the most searched stocks. Should you jump on the bandwagon?

Resignation of Chief Financial Officer (CFO) - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts, expert advice, ...

The US has built three reactors in the past 30 years, but now Westinghouse will stand up 10 in partnership with Google. But ...

Following our analysis of the options activities associated with Vertex Pharmaceuticals, we pivot to a closer look at the company's own performance. Where Is Vertex Pharmaceuticals Standing Right Now?

All this makes Vertex look like a bargain right now -- and at this level, you may want to buy shares like there's no tomorrow. Should you invest $1,000 in Vertex Pharmaceuticals right now?

Vertex had plans to hire 1,300 employees in Wilmington, but it never even got close.

Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) were sinking 11.9% as of 10:18 a.m. ET on Tuesday. The sharp decline came after the company announced its 2025 first-quarter results on Monday evening.

Change in Management - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts, expert advice, and more to stay ...